These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17310999)

  • 1. Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen.
    Bubman D; Guasparri I; Cesarman E
    Oncogene; 2007 Jul; 26(34):4979-86. PubMed ID: 17310999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc.
    Liu J; Martin HJ; Liao G; Hayward SD
    J Virol; 2007 Oct; 81(19):10451-9. PubMed ID: 17634226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta.
    Fujimuro M; Hayward SD
    J Virol; 2003 Jul; 77(14):8019-30. PubMed ID: 12829841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency.
    Fujimuro M; Wu FY; ApRhys C; Kajumbula H; Young DB; Hayward GS; Hayward SD
    Nat Med; 2003 Mar; 9(3):300-6. PubMed ID: 12592400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi's sarcoma-associated herpesvirus LANA protein downregulates nuclear glycogen synthase kinase 3 activity and consequently blocks differentiation.
    Liu J; Martin H; Shamay M; Woodard C; Tang QQ; Hayward SD
    J Virol; 2007 May; 81(9):4722-31. PubMed ID: 17314169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP.
    Woodard C; Liao G; Goodwin CR; Hu J; Xie Z; Dos Reis TF; Newman R; Rho H; Qian J; Zhu H; Hayward SD
    J Virol; 2015 Sep; 89(18):9232-41. PubMed ID: 26109723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen.
    Fujimuro M; Liu J; Zhu J; Yokosawa H; Hayward SD
    J Virol; 2005 Aug; 79(16):10429-41. PubMed ID: 16051835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA.
    Muromoto R; Okabe K; Fujimuro M; Sugiyama K; Yokosawa H; Seya T; Matsuda T
    FEBS Lett; 2006 Jan; 580(1):93-8. PubMed ID: 16364321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors.
    Tolani B; Gopalakrishnan R; Punj V; Matta H; Chaudhary PM
    Oncogene; 2014 May; 33(22):2928-37. PubMed ID: 23792448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's sarcoma-associated herpesvirus-encoded LANA associates with glucocorticoid receptor and enhances its transcriptional activities.
    Togi S; Nakasuji M; Muromoto R; Ikeda O; Okabe K; Kitai Y; Kon S; Oritani K; Matsuda T
    Biochem Biophys Res Commun; 2015 Jul; 463(3):395-400. PubMed ID: 26032496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus.
    Verma SC; Bajaj BG; Cai Q; Si H; Seelhammer T; Robertson ES
    J Virol; 2006 Nov; 80(22):11178-90. PubMed ID: 16928741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia.
    Cai Q; Murakami M; Si H; Robertson ES
    J Virol; 2007 Oct; 81(19):10413-23. PubMed ID: 17634230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the interaction between latency-associated nuclear antigen and glycogen synthase kinase 3beta.
    Hagen T
    J Virol; 2009 Jun; 83(12):6312-7. PubMed ID: 19321622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myc is required for the maintenance of Kaposi's sarcoma-associated herpesvirus latency.
    Li X; Chen S; Feng J; Deng H; Sun R
    J Virol; 2010 Sep; 84(17):8945-8. PubMed ID: 20573831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human I-mfa domain proteins specifically interact with KSHV LANA and affect its regulation of Wnt signaling-dependent transcription.
    Kusano S; Eizuru Y
    Biochem Biophys Res Commun; 2010 Jun; 396(3):608-13. PubMed ID: 20417616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function.
    Si H; Robertson ES
    J Virol; 2006 Jan; 80(2):697-709. PubMed ID: 16378973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions.
    Cai Q; Lan K; Verma SC; Si H; Lin D; Robertson ES
    J Virol; 2006 Aug; 80(16):7965-75. PubMed ID: 16873253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.
    Rivas C; Thlick AE; Parravicini C; Moore PS; Chang Y
    J Virol; 2001 Jan; 75(1):429-38. PubMed ID: 11119611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas.
    Chen W; Hilton IB; Staudt MR; Burd CE; Dittmer DP
    J Virol; 2010 Apr; 84(8):3898-908. PubMed ID: 20130056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of the chromatin binding domain of KSHV LANA.
    Woodard C; Shamay M; Liao G; Zhu J; Ng AN; Li R; Newman R; Rho HS; Hu J; Wan J; Qian J; Zhu H; Hayward SD
    PLoS Pathog; 2012; 8(10):e1002972. PubMed ID: 23093938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.